343 related articles for article (PubMed ID: 6865023)
1. [Influence of the protein induced by vitamin K absence on thrombotest and hepaplastintest in the patients treated with oral anticoagulant].
Murakami S; Muratani H; Kikuchi T; Fujimoto S; Hayashi T; Inai S; Imaoka S
Rinsho Byori; 1983 Jan; 31(1):105-9. PubMed ID: 6865023
[No Abstract] [Full Text] [Related]
2. Levels of acarboxy prothrombin (PIVKA-II) and coagulation factors in warfarin-treated patients.
Umeki S; Umeki Y
Med Lab Sci; 1990 Apr; 47(2):103-7. PubMed ID: 2381266
[TBL] [Abstract][Full Text] [Related]
3. Protein C level at birth.
Polack B; Pouzol P; Amiral J; Kolodie L
Thromb Haemost; 1984 Oct; 52(2):188-91. PubMed ID: 6549231
[TBL] [Abstract][Full Text] [Related]
4. Spectrophotometric assays of prothrombin in plasma of patients using oral anticoagulants.
Bertina RM; van der Marel-van Nieuwkoop W; Loeliger EA
Thromb Haemost; 1979 Dec; 42(4):1296-305. PubMed ID: 542935
[TBL] [Abstract][Full Text] [Related]
5. The pharmacodynamics of the oral anticoagulant drugs.
O'Reilly RA
Prog Hemost Thromb; 1974; 2(0):175-213. PubMed ID: 4137288
[No Abstract] [Full Text] [Related]
6. [Quick's time and derived times in the study of the extrinsic course of the coagulation process. The PIVKA (protein induced by vitamin K absence or antagonists) in states of chronic disseminated intravascular coagulation].
Moscarella S; Ventimiglia V
Quad Sclavo Diagn; 1974 Dec; 10(4):463-73. PubMed ID: 4460075
[TBL] [Abstract][Full Text] [Related]
7. Effect of vitamin K on clotting factors in children with congenital cyanotic heart disease.
Goldschmidt B
Acta Paediatr Acad Sci Hung; 1970; 11(2):135-9. PubMed ID: 5504583
[No Abstract] [Full Text] [Related]
8. Biological properties of the thromboplastins and plasmas included in the ICTH/ICSH collaborative study on prothrombin time standardization.
Loeliger EA; van Halem-Visser LP
Thromb Haemost; 1979 Dec; 42(4):1115-27. PubMed ID: 542924
[No Abstract] [Full Text] [Related]
9. The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment.
Bertina RM; Westhoek-Kuipers ME; Alderkamp GH
Thromb Haemost; 1981 Jun; 45(3):237-41. PubMed ID: 7281102
[TBL] [Abstract][Full Text] [Related]
10. Oral anticoagulants.
Winter JH; Douglas AS
Clin Haematol; 1981 Jun; 10(2):459-80. PubMed ID: 7032784
[No Abstract] [Full Text] [Related]
11. Mechanism of action and monitoring of anticoagulants.
Hirsh J
Semin Thromb Hemost; 1986 Jan; 12(1):1-11. PubMed ID: 3961504
[No Abstract] [Full Text] [Related]
12. Concurrent lupus anticoagulants and prothrombin deficiency due to phenytoin use.
Harrison RL; Alperin JB; Kumar D
Arch Pathol Lab Med; 1987 Aug; 111(8):719-22. PubMed ID: 3115223
[TBL] [Abstract][Full Text] [Related]
13. An alternative extrinsic coagulation pathway and oral anticoagulant treatment.
Cassetti M; Palazzesi G; Trimarchi A; Barzetta R
Quad Sclavo Diagn; 1984 Mar; 20(1):105-9. PubMed ID: 6494410
[No Abstract] [Full Text] [Related]
14. Proceedings: The relation between staphylocoagulase reacting factor and proteins induced by vitamin K absence.
Bas BM; Muller AD; Hemker HC
Thromb Diath Haemorrh; 1975 Nov; 34(2):593. PubMed ID: 1198506
[No Abstract] [Full Text] [Related]
15. [Comparison between the dilution curves of prothrombin time and activated partial thromboplastin time for the control of the effect of anti-vitamin K].
Langer B; Fuess VL; Kauffman P; Bechara MJ; dos Reis JM; Kwang WT
Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(1):18-22. PubMed ID: 6385200
[No Abstract] [Full Text] [Related]
16. Prevention of subclinical vitamin K deficiency based on PIVKA-II levels: oral versus intramuscular route.
Bakhshi S; Deorari AK; Roy S; Paul VK; Singh M
Indian Pediatr; 1996 Dec; 33(12):1040-3. PubMed ID: 9141807
[No Abstract] [Full Text] [Related]
17. Detection and clinical significance of PIVKA.
Veltkamp JJ
Mayo Clin Proc; 1974 Dec; 49(12):923-4. PubMed ID: 4444340
[No Abstract] [Full Text] [Related]
18. [Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin III complex(TAT) and thrombophilia parameters in orally anticoagulated patients with inferior vena cava filters].
Halbmayer WM; Haushofer A; Toth E
Wien Med Wochenschr; 1993; 143(5):95-8. PubMed ID: 8511904
[TBL] [Abstract][Full Text] [Related]
19. The effect of combined antenatal vitamin K and phenobarbital therapy on umbilical blood coagulation studies in infants less than 34 weeks' gestation.
Thorp JA; Caspers DR; Cohen GR; Zucker ML; Strope BD; McKenzie DR
Obstet Gynecol; 1995 Dec; 86(6):982-9. PubMed ID: 7501353
[TBL] [Abstract][Full Text] [Related]
20. Congenital deficiency of vitamin K-dependent coagulation factors and protein C.
Vicente V; Maia R; Alberca I; Tamagnini GP; Lopez Borrasca A
Thromb Haemost; 1984 Jul; 51(3):343-6. PubMed ID: 6548583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
